Lindenwold Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,605
| Closed | -$893K | – | 112 |
|
|
2024
Q3 | $893K | Buy |
4,605
+55
| +1% | +$10.7K | 0.45% | 56 |
|
|
2024
Q2 | $1.05M | Buy |
4,550
+30
| +0.7% | +$6.96K | 0.56% | 51 |
|
|
2024
Q1 | $975K | Buy |
4,520
+1,640
| +57% | +$354K | 0.52% | 52 |
|
|
2023
Q4 | $745K | Sell |
2,880
-1,804
| -39% | -$467K | 0.42% | 55 |
|
|
2023
Q3 | $1.2M | Buy |
4,684
+29
| +0.6% | +$7.45K | 0.75% | 44 |
|
|
2023
Q2 | $1.33M | Sell |
4,655
-845
| -15% | -$241K | 0.81% | 41 |
|
|
2023
Q1 | $1.53M | Buy |
5,500
+70
| +1% | +$19.5K | 0.95% | 38 |
|
|
2022
Q4 | $1.5M | Buy |
5,430
+54
| +1% | +$15K | 1.01% | 37 |
|
|
2022
Q3 | $1.44M | Buy |
5,376
+38
| +0.7% | +$10.1K | 1.06% | 32 |
|
|
2022
Q2 | $1.09M | Buy |
5,338
+31
| +0.6% | +$6.32K | 0.77% | 48 |
|
|
2022
Q1 | $1.12M | Buy |
5,307
+209
| +4% | +$44K | 0.69% | 48 |
|
|
2021
Q4 | $1.22M | Buy |
+5,098
| New | +$1.22M | 0.71% | 47 |
|